SYRA logo

Syra Health Corp. Class A Common Stock (SYRA) Hisse Analizi

Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

$'dan işlem gören Syra Health Corp. Class A Common Stock (SYRA), 0 değerindeki bir Healthcare şirketidir.

Son analiz: 16 Mar 2026

Syra Health Corp. Class A Common Stock (SYRA) Sağlık ve Boru Hattı Genel Bakışı

CEOGregory R. Alexander
Çalışanlar57
MerkezCarmel, US
Halka Arz Yılı2023
SektörHealthcare

Syra Health Corp. delivers health education, population health management, and digital health solutions, targeting mental health facilities and government agencies. With a focus on telehealth and digital transformation, Syra operates in the evolving healthcare services sector, marked by a negative profit margin and high beta.

Veri Kaynağı | Finansal Veriler Kantitatif Analiz NASDAQ Analiz: 16 Mar 2026

Yatırım Tezi

Syra Health Corp. operates in the growing healthcare services market, with a focus on digital health and telehealth solutions. The company's diverse service offerings, including health education, population health management, and mental health services, position it to capitalize on the increasing demand for integrated healthcare solutions. Key value drivers include the expansion of its Syrenity telehealth platform and the growth of its digital health solutions. However, the company's negative profit margin of -12.4% and high beta of 3.96 indicate significant financial risk. The company's small market capitalization also presents liquidity concerns. Investors should carefully weigh the growth potential against the financial risks before considering an investment in Syra Health.

FMP finansallarına ve nicel analizine dayanmaktadır

Temel Önemli Noktalar

  • Syra Health Corp. operates with a market capitalization of $0.00B, indicating its status as a micro-cap company.
  • The company's P/E ratio is -1.40, reflecting its current lack of profitability.
  • Syra Health Corp. has a negative profit margin of -12.4%, highlighting challenges in achieving profitability.
  • The company's gross margin is 29.8%, suggesting potential for improved profitability with efficient cost management.
  • Syra Health Corp. has a high beta of 3.96, indicating significant volatility compared to the broader market.

Rakipler & Benzerleri

Güçlü Yönler

  • Diverse service offerings including health education, population health management, and digital health.
  • Focus on telehealth and digital health solutions.
  • Strong relationships with mental health hospitals and government agencies.
  • Development of proprietary Syrenity telehealth platform.

Zayıflıklar

  • Negative profit margin indicating financial challenges.
  • Small market capitalization and limited financial resources.
  • High beta indicating significant volatility.
  • Limited brand recognition compared to larger competitors.

Katalizörler

  • Ongoing: Expansion of Syrenity telehealth platform to increase market reach and service offerings.
  • Ongoing: Growth in digital health solutions to capitalize on the increasing adoption of digital healthcare technologies.
  • Ongoing: Strategic partnerships with healthcare organizations to expand service delivery and customer base.
  • Ongoing: Development and launch of new health education programs to improve patient outcomes and engagement.
  • Ongoing: Expansion of healthcare staffing solutions to address the growing shortage of healthcare professionals.

Riskler

  • Potential: Intense competition from larger, more established players in the healthcare services industry.
  • Potential: Regulatory changes and healthcare reform that could impact the company's business model.
  • Potential: Economic downturn that could reduce demand for healthcare services.
  • Potential: Cybersecurity threats and data breaches that could compromise patient data and damage the company's reputation.
  • Ongoing: Negative profit margin indicating financial challenges and potential liquidity issues.

Büyüme Fırsatları

  • Growth opportunity 1: Expansion of Syrenity Telehealth Platform: Syra Health's development of Syrenity, an on-demand telehealth platform for mental health services, presents a significant growth opportunity. The telehealth market is projected to reach $55.6 billion by 2027, driven by increasing demand for remote healthcare services. By expanding the features and reach of Syrenity, Syra Health can capture a larger share of this growing market and improve access to mental health services. Timeline: Ongoing.
  • Growth opportunity 2: Digital Health Solutions: Syra Health's digital health solutions, including digital transformation, cloud and security, artificial intelligence, patient engagement, and health apps, offer substantial growth potential. The digital health market is expected to reach $379 billion by 2024, fueled by the increasing adoption of digital technologies in healthcare. By developing innovative digital health solutions tailored to the needs of its clients, Syra Health can drive revenue growth and enhance its competitive position. Timeline: Ongoing.
  • Growth opportunity 3: Healthcare Workforce Solutions: Syra Health's healthcare staffing solutions address the growing demand for qualified healthcare professionals. The healthcare staffing market is projected to reach $44.7 billion by 2027, driven by shortages of nurses, physicians, and other healthcare workers. By providing flexible and cost-effective staffing solutions, Syra Health can help healthcare organizations meet their workforce needs and improve patient care. Timeline: Ongoing.
  • Growth opportunity 4: Population Health Management Services: Syra Health's population health management services, including analytics as a service, epidemiology, and health equity analytics solutions, offer a valuable service to healthcare organizations seeking to improve patient outcomes and reduce costs. The population health management market is expected to reach $69.2 billion by 2027, driven by the increasing focus on value-based care and preventative medicine. By providing data-driven insights and solutions, Syra Health can help healthcare organizations optimize their population health management strategies. Timeline: Ongoing.
  • Growth opportunity 5: Health Education Services: Syra Health's health education services, including medical communications, patient education, and healthcare training, address the critical need for effective communication and education in healthcare. The health education market is expected to grow as healthcare organizations increasingly recognize the importance of patient engagement and adherence. By providing engaging and informative health education programs, Syra Health can help improve patient outcomes and satisfaction. Timeline: Ongoing.

Fırsatlar

  • Expansion of Syrenity telehealth platform to capture a larger share of the telehealth market.
  • Growth of digital health solutions to meet the increasing demand for digital healthcare technologies.
  • Expansion of healthcare staffing solutions to address the growing shortage of healthcare professionals.
  • Leveraging population health management services to capitalize on the increasing focus on value-based care.

Tehditler

  • Intense competition from larger, more established players in the healthcare services industry.
  • Regulatory changes and healthcare reform that could impact the company's business model.
  • Economic downturn that could reduce demand for healthcare services.
  • Cybersecurity threats and data breaches that could compromise patient data and damage the company's reputation.

Rekabet Avantajları

  • Diverse service offerings provide a comprehensive suite of healthcare solutions.
  • Focus on digital health and telehealth solutions positions the company for future growth.
  • Strong relationships with mental health hospitals and government agencies.
  • Proprietary Syrenity telehealth platform offers a competitive advantage.

SYRA Hakkında

Syra Health Corp., established in 2020 and headquartered in Carmel, Indiana, is a healthcare services company that provides a suite of solutions, including health education, population health management, behavioral and mental health services, healthcare workforce solutions, and digital health services. The company's health education services encompass medical communications, patient education, and healthcare training programs. Its population health management services include analytics as a service, epidemiology, and health equity analytics solutions, designed to improve patient outcomes and reduce healthcare costs. Syra Health is also developing Syrenity, a telehealth platform focused on delivering mental health services on-demand. Furthermore, the company offers healthcare staffing solutions and digital health solutions, including digital transformation, cloud and security, artificial intelligence, patient engagement, and health apps. Syra Health serves a diverse clientele, including mental health hospitals, government agencies, integrated health networks, managed care entities, and pharmaceutical manufacturers, positioning itself as a versatile partner in the healthcare ecosystem.

Ne Yaparlar

  • Provides health education services, including medical communications and patient education.
  • Offers population health management services, such as analytics and epidemiology solutions.
  • Develops Syrenity, an on-demand telehealth platform for mental health services.
  • Provides healthcare staffing solutions to hospitals and healthcare organizations.
  • Offers digital health solutions, including digital transformation and cloud security.
  • Serves mental health hospitals, government agencies, and managed care entities.

İş Modeli

  • Generates revenue through health education services provided to healthcare organizations.
  • Earns revenue from population health management services, including data analytics and consulting.
  • Monetizes its Syrenity telehealth platform through subscription fees and service charges.
  • Derives income from healthcare staffing solutions provided to hospitals and clinics.

Sektör Bağlamı

Syra Health Corp. operates within the healthcare services industry, which is experiencing significant growth due to factors such as an aging population, increasing prevalence of chronic diseases, and advancements in technology. The industry is characterized by intense competition, with companies vying for market share in areas such as telehealth, digital health, and population health management. Syra Health's focus on integrated healthcare solutions and its diverse service offerings position it to compete effectively in this dynamic landscape. However, the company faces challenges from larger, more established players with greater resources and brand recognition.

Kilit Müşteriler

  • Mental health hospitals and organizations seeking comprehensive healthcare solutions.
  • Government agencies requiring population health management and health education services.
  • Integrated health networks looking for digital health and telehealth solutions.
  • Managed care entities seeking to improve patient outcomes and reduce healthcare costs.
  • Pharmaceutical manufacturers requiring medical communications and patient education programs.
AI Güveni: 69% Güncellendi: 16 Mar 2026

Finansallar

Grafik & Bilgi

Syra Health Corp. Class A Common Stock (SYRA) hisse senedi fiyatı: Price data unavailable

Son Haberler

Analist Konsensüsü

Fikir Birliği Derecelendirmesi

SYRA için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.

Fiyat Hedefleri

SYRA için Wall Street fiyat hedefi analizi.

MoonshotScore

0/100

Bu puan ne anlama geliyor?

MoonshotScore, SYRA'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.

En Son Syra Health Corp. Class A Common Stock Analizi

Yönetim: Gregory R. Alexander

Unknown

Information about Gregory R. Alexander's background is not available in the provided context. Therefore, his career history, education, and previous roles are unknown. Further research would be needed to provide a comprehensive biography.

Sicil: Information about Gregory R. Alexander's track record is not available in the provided context. Key achievements, strategic decisions, and company milestones under his leadership are unknown. Further research would be needed to evaluate his performance as CEO.

SYRA OTC Piyasa Bilgileri

The OTC Other tier represents the lowest tier of the OTC market, indicating that Syra Health Corp. may not meet the minimum financial standards or reporting requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial disclosure, making it more difficult for investors to assess their financial health and performance. Investing in companies on the OTC Other tier carries a higher degree of risk compared to those listed on major exchanges like the NYSE or NASDAQ due to the lack of regulatory oversight and transparency.

  • OTC Katmanı: OTC Other
  • Açıklama Durumu: Unknown
Likidite: Liquidity assessment for Syra Health Corp. is challenging due to its OTC Other listing. Typically, stocks in this tier exhibit lower trading volumes and wider bid-ask spreads compared to those on major exchanges. This can make it difficult for investors to buy or sell shares quickly and efficiently, potentially leading to price volatility and increased transaction costs.
OTC Risk Faktörleri:
  • Limited financial disclosure increases the risk of investing in Syra Health Corp.
  • Lower trading volumes and wider bid-ask spreads can lead to price volatility and illiquidity.
  • Lack of regulatory oversight on the OTC Other tier increases the potential for fraud and manipulation.
  • Limited access to capital markets can hinder the company's ability to raise funds for growth and expansion.
  • The OTC Other tier may attract speculative trading, increasing the risk of sudden price swings.
Durum Tespiti Kontrol Listesi:
  • Verify the company's financial statements and SEC filings (if any).
  • Research the company's management team and their track record.
  • Assess the company's business model and competitive landscape.
  • Evaluate the company's growth prospects and potential risks.
  • Consult with a financial advisor before investing.
  • Check for any legal or regulatory issues involving the company.
  • Understand the risks associated with investing in OTC stocks.
Meşruiyet Sinyalleri:
  • Company incorporation in 2020 suggests a relatively new business.
  • Headquarters located in Carmel, Indiana.
  • Provides a range of healthcare services, including health education and digital health solutions.
  • Serves mental health hospitals and government agencies.

Yatırımcılar Syra Health Corp. Class A Common Stock (SYRA) Hakkında Ne Soruyor

SYRA için değerlendirilmesi gereken temel faktörler nelerdir?

SYRA'ı değerlendirmek, temelleri, analist konsensüsünü ve risk faktörlerini gözden geçirmeyi içerir. Temel güçlü yan: Diverse service offerings including health education, population health management, and digital health.. İzlenmesi gereken birincil risk: Potential: Intense competition from larger, more established players in the healthcare services industry.. Bu bir finansal tavsiye değildir.

SYRA MoonshotScore'u nedir?

MoonshotScore, SYRA'ı finansal sağlık, piyasa momentumu ve risk faktörleri genelinde 0 ile 100 arasında derecelendirir. 70'in üzerindeki puanlar daha yüksek derecelendirmeleri, 50-70 arası orta ve 50'nin altı daha düşük derecelendirmeleri gösterir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.

SYRA verileri ne sıklıkla güncellenir?

SYRA fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.

Analistler SYRA hakkında ne diyor?

SYRA için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.

SYRA'a yatırım yapmanın riskleri nelerdir?

SYRA için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Potential: Intense competition from larger, more established players in the healthcare services industry.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.

SYRA'ın P/E oranı nedir?

SYRA için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için SYRA'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.

SYRA aşırı değerli mi, yoksa düşük değerli mi?

Syra Health Corp. Class A Common Stock (SYRA)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.

SYRA'ın temettü verimi nedir?

Syra Health Corp. Class A Common Stock (SYRA) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.

Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.

Resmi Kaynaklar

Analiz güncellendi
Veri Kaynakları ve Metodoloji
Piyasa verileri Financial Modeling Prep ve Yahoo Finance tarafından sağlanmaktadır. AI analizi Stock Expert AI tescilli algoritmaları ile yapılmaktadır. Teknik göstergeler endüstri standardı hesaplamalarla üretilmektedir. Son güncelleme: .

Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.

Analiz Notları
  • Information is based on available data as of March 16, 2026.
  • OTC market data may be limited or delayed.
  • AI analysis is pending and may provide further insights.
Veri Kaynakları

Popüler Hisseler